JP Morgan Chase
INO icon

JP Morgan Chase’s Inovio Pharmaceuticals INO Stock Holding History

JP Morgan Chase’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,250
Closed -$209K – 7113
2023
Q1 		$209K Hold
21,250
– – ﹤0.01% 5040
2022
Q4 		$398K Hold
21,250
– – ﹤0.01% 4659
2022
Q3 		$440K Hold
21,250
– – ﹤0.01% 4544
2022
Q2 		$441K Buy
+21,250
New +$599K ﹤0.01% 4643
2020
Q4 		– Sell
-16,850
Closed -$2.29M – 5768
2020
Q3 		$2.29M Sell
16,850
-22,825
-58% -$4.76M ﹤0.01% 3138
2020
Q2 		$12.8M Buy
39,675
+11,583
+41% +$1.86M ﹤0.01% 1707
2020
Q1 		$2.51M Buy
+28,092
New +$1.73M ﹤0.01% 2791

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return